Almac Group is proud of its global reputation for excellence, delivering expertise right across the drug development lifecycle and offering a tailored solution to each client.
Our client relationships are long term and they are underpinned by one simple commitment:
We will be exceptional, always.
Latest from Almac
September 26th, 2019
Almac’s unique gene expression report enables cancer researchers to discover exciting new insights
September 25th, 2019
Almac Pharma Services Achieves Unprecedented Global Regulatory Milestone
September 17th, 2019
Almac Group Participates in Global Clinical Supply BlockChain Working Group
Almac Brexit Resource Hub
Partnering to advance human healthExplore our locations
Almac recognizes that you need bespoke solutions to suit your needs. Only we can combine the expertise from our world leading range of specialized drug development services to support you across the full biopharmaceutical product lifecycle, from the preclinical stages through to commercialization.
Almac Diagnostic Services is our stratified medicine business unit, specializing in biomarker driven clinical trials. Our global laboratories, in the UK and US, offer tailored solutions from discovery to commercialization: biomarker discovery, assay development & validation, CDx development & commercialization. Your clinical trial diagnostic partner.
Almac Discovery is a research driven, oncology business unit within Almac dedicated to the discovery and development of novel, innovative approaches to the treatment of cancer. We focus on early stage development and partner programs with the pharmaceutical industry at the discovery to preclinical stage.
Clinical Trial Supply Nordics
22 October 2019 Copenhagen, DenmarkEvent info
GCSG 2019 European Knowledge Forum
22 October 2019 Cascais, PortugalEvent info
AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
26 October 2019 Boston, MAEvent info
CBI IRT 2019
29 October 2019 Philadelphia, PAEvent info